Viking Therapeutics, Inc. (VKTX): 305B2 filed Sep 24, 2026

Form type

305B2

Filing date

Sep 24, 2026

Accession number

0001213900-26-102782

Filer

Viking Therapeutics, Inc. (CIK 1607678)